Neurodevelopmental evaluation of at-risk infants is important for their global development in follow-up clinics. The SINDA neurological scale is a valid and reliable tool to evaluate at-risk infants (
9). This study is the first to investigate the psychometric properties of the Turkish version of the SINDA neurological scale for at-risk infants. Based on the findings of this study, the Turkish version of the SINDA neurological scale, which is a predictor of atypical neurodevelopmental outcomes among at-risk infants aged between 0 and 12 months, is a valid and reliable instrument.
Cronbach’s alpha values for each subdimension of the SINDA neurological scale are presented in
Table 2. The factor loads of the subdimensions of the SINDA neurological scale were sufficient because the Cronbach’s alpha was above 0.70 (0.84). Therefore, the six subsections of the SINDA neurological scale measure separate features. The questionnaire we created according to these results is a reliable measurement tool. The total correlation values of the dimensions in our scale varied between 0.47 and 0.77, making any reductions in the dimensions of the SINDA neurological scale unnecessary.
The Kaiser-Meyer-Olkin (KMO) test assesses whether the distribution is adequate for factor analysis, and a range of 0.80 - 0.90 is considered excellent (
18). Therefore, the KMO value in this study is at an excellent level. This measurement shows that the variable we examined is multivariate in the universe parameter. In this study, no limitation was placed on the number of factors, and factors with an eigenvalue equal to or greater than 1 were accepted as important factors (
19). Considering that variance rates ranging from 40% to 60% are considered ideal in factor analysis, the amount of variance obtained in this study is at a sufficient level (
20).
According to the results of our confirmatory factor analysis, the scale is suitable for Turkish culture. The results of our confirmatory factor analysis regarding construct validity support the six-factor structure of the original scale, and factor loadings were acceptable. The fit index values obtained showed that the model was in good agreement (
21). The ratio of chi-square to degrees of freedom and fit indices is a method used to determine fit in cases where it is shown to be important in large samples (
22). Confirmatory Factor Analysis is used to check whether the scale conforms to the original factor structure when used in the current research, and if so, to what extent. The results of the confirmatory factor analysis concerning structural validity support the original scale's six-factor structure. The fit index values obtained from confirmatory factor analysis have shown that the model is a good fit. In other words, each factor accurately represents the questions that comprise it. Our current confirmatory factor analysis results indicate that the scale is suitable for Turkish culture.
The SINDA neurological scale consists of six subsections and 28 questions. The results of the study showed that the scale had good inter-rater reliability. As a result of these evaluations, measurements made at different times show high similarity in dimensions. Therefore, the Turkish version of the SINDA neurological scale has high intra-rater and inter-rater reliability (
22).
The ICCs were evaluated for the six subdimensions and three measurements for the total score obtained. These evaluations indicated high similarity in dimensions for measurements made at different times. To account for the growth and development of babies, the ICC was high because the evaluations were repeated within a short time period. As a result, the Turkish version of the SINDA neurological scale demonstrates high intra-rater and inter-rater reliability. Our results are similar to the intra-rater and inter-rater reliability values obtained in the original study of the scale (
9).
In this study, the HINE and AIMS, known to be valid and reliable, were used to evaluate the concurrent validity of the Turkish version of the SINDA neurological scale. Early neuromotor or neurodevelopmental assessments should be valid, reliable, and capable of performing perinatal and early postnatal assessments. AIMS is one of the frequently used early neurodevelopmental test batteries with proven validity and reliability. It is stated that AIMS also evaluates the quality of movement and changes in motor skills (
23). Studies (
15,
24-
26). have noted that AIMS is useful in determining neurological risk in infants in the early period. Liao and others (
27). stated that AIMS is most sensitive in the evaluation of babies between 3 and 12 months. The HINE test, applied to determine the higher risk of neurological anomalies in preterm and term babies at other stages of their lives, is a preventive battery for detecting neural disorders in the early period (
28). SINDA is also found to be a reliable and valid method as a screening tool in infancy. The correlation of the SINDA neurological scale with the HINE was r = 0.72, and its relationship with the AIMS was r = 0.64. These results show that the Turkish version of the SINDA neurological scale is valid.
Hadders-Algra’s original study reported 21 total SINDA neurological scale scores with 0.89 sensitivity and 0.93 specificity as the limit for atypical neurodevelopmental risk for children aged 24 months and older (
9). Considering that 40.85% (n = 29) of the infants included in this study had a score of 21 and below, these infants have atypical neurodevelopmental risk and should be followed closely.
Infant neurodevelopmental assessments serve dual purposes. Initially, they focus on evaluating the current developmental state of the infant. Understanding the infant's present condition enables professionals to educate caregivers about their child's attributes and offer guidance on fostering their development, whether through professional early intervention or other means. Additionally, these assessments are utilized to anticipate and identify potential developmental disorders in at-risk populations (
16,
29). In this study, SINDA’s neurological scale evaluated neuromotor development very well, paralleling other test batteries HINE and AIMS. These results show that SINDA’s neurological scale can be used in clinics for the early evaluation of at-risk infants, enabling earlier interventions and improved outcomes for infants in the Turkish population.
The limitation of this study was the lack of evaluation of the effects of clinical sociodemographic factors of the infants on neuromotor development. Interaction effects of gender, level of risk of the infants, and sociodemographic factors were not investigated, which might have affected the results. Further studies could determine if clinical properties and the sociodemographic factors of the infants affect neuromotor development as assessed with SINDA’s neurological scale.
5.1. Conclusions
Overall, this study demonstrated the reliability and discriminative validity of the Turkish version of the SINDA neurological scale. The Turkish version of the SINDA neurological scale is a valid and reliable tool, and we believe it will be a valuable asset in clinics as a fast and effective method for evaluating the neurodevelopment of at-risk infants in the Turkish population. The strengths of this study include the translation and adaptation process based on international guidelines and the inclusion of a large sample size with a wide age range. Furthermore, participants were recruited from several centers in different cities in Turkey, which might positively influence the generalizability of the scale.
In clinical settings, the Turkish version of the SINDA can be employed to assess the neurodevelopment of at-risk infants. This assessment provides insights into neuromotor outcomes, guiding professionals in determining suitable intervention methods and facilitating early intervention efforts.